Stocktitan

Published September 23, 2026

Clearmind highlights 3 U.S. psychedelic patent bids | CMND SEC Filing - Form 6-K

Read the full story at Stocktitan

Three U.S. applications pair LSD , ketamine and ibogaine with PEA for depression, PTSD and substance use, taking Clearmind to 19 patent families.